Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response?
von Hertzen
L C
LC
The Finnish Lung Health Association; and Helsinki University Central Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Haahtela
T
T
D000818:Animals; D001249:Asthma / Q000276:immunology / Q000517:prevention & control*; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000517:prevention & control*; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology
D001428:Bacterial Vaccines